Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Evertsson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Communications Biology|December 5, 2019
Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligandsAnna Y Belorusova, Emma Evertsson, Daniel Hovdal, et al.
Nature Reviews. Drug Discovery|July 7, 2025
The changing landscape of medicinal chemistry optimizationAnita Rácz, Levente M Mihalovits, Maximilian Beckers, et al.
Journal of Medicinal Chemistry|September 26, 2014
Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitorsJohn G Cumming, Judit É Debreczeni, Fredrik Edfeldt, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein InteractionLeifeng Cheng, Daniel Pettersen, Bengt Ohlsson, et al.
Chemmedchem|July 21, 2019
An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation InhibitorsUlf Hedström, Monica Norberg, Emma Evertsson, et al.
The Journal of Biological Chemistry|March 6, 2020
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain functionJenny Sandmark, Anna Tigerström, Tomas Akerud, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Communications Biology|December 5, 2019
Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligandsAnna Y Belorusova, Emma Evertsson, Daniel Hovdal, et al.
Nature Reviews. Drug Discovery|July 7, 2025
The changing landscape of medicinal chemistry optimizationAnita Rácz, Levente M Mihalovits, Maximilian Beckers, et al.
Journal of Medicinal Chemistry|September 26, 2014
Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitorsJohn G Cumming, Judit É Debreczeni, Fredrik Edfeldt, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein InteractionLeifeng Cheng, Daniel Pettersen, Bengt Ohlsson, et al.
Chemmedchem|July 21, 2019
An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation InhibitorsUlf Hedström, Monica Norberg, Emma Evertsson, et al.
The Journal of Biological Chemistry|March 6, 2020
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain functionJenny Sandmark, Anna Tigerström, Tomas Akerud, et al.
Pageof 2